QuickView for leucyl-tRNA aminoacylation (biogroup)

1. L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
2. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
3. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
4. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
5. L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)

1. A naturally occurring nonapeptide functionally compensates for the CP1 domain of leucyl-tRNA synthet…
2. Chemical modification of tryptophan residues of leucyl tRNA synthetase by N-bromosuccinimide and 2-h…

There were no clinical trials for leucyl-tRNA aminoacylation